Dr. Ekaterina (Kate) Dadachova joined U of S in November 2016. She is a Professor of Pharmacy at the College of Pharmacy and Nutrition and the Fedoruk Centre for Nuclear Innovation Chair in Radiopharmacy. Before joining U of S she was a Professor of Radiology, Microbiology and Immunology in the Albert Einstein College of Medicine in New York, USA, where she was also Sylvia and Robert S. Olnick Faculty Scholar in Cancer Research. She received her PhD in Physical Chemistry from Moscow State University in Moscow, Russia, in 1992, and completed a postdoctoral fellowship in radiopharmaceutical chemistry at the Australian Nuclear Science and Technology Organization in Sydney, Australia.
Research
Dadachova’s laboratory has pioneered the treatment of infectious diseases including fungal and bacterial infections and HIV with radiolabeled antibodies (so called radioimmunotherapy). Her other research interests are radioimmunotherapy of melanoma, blood cancers and osteosarcoma as well as the development of melanin-based radioprotectors for cancer patients undergoing radiation therapy, soldiers on the battlefield and astronauts in space. She has an active research program which is funded by the Canadian Institutes of Health Research (CIHR), Saskatchewan Health Research Fund (SHRF), Canadian Space Agency (CSA), United States Department of Defense, National Institutes of Health (NIH), and pharmaceutical industry. In 2020 she was recognized with a Distinguished Researcher Award by U of S.